Press Releases

Ethos Discovery Announces Multidisciplinary Strategic Research Collaboration to FurtherEthos-PUSH Study Aimed at Finding a Cure for Hemangiosarcoma

Meredith Caggiano of Ethos Veterinary Health,Named One of Center for Women & Wealth’s 21 Women to Watch in 2021

In honor of the 51st annual Earth Day, Ethos Veterinary Health is proud to announce our partnership with the National Forest Foundation (NFF) as a way to improve the environment and recognize our employees, and their dedication to the natural world.

"We are delighted to welcome [Drs. Chand Khanna and Lee Helman] as new directors. They will be of great help in advancing our unique approach to the discovery and development of metastatic progression targeting cancer treatments in osteosarcoma and other cancers." Dr. David Warshawsky, Vuja De’s Founder and Chairman of the Board.

WOBURN, Mass. — Nov. 15, 2019: IBM will collaborate with VetBloom, the digital learning ecosystem from Ethos Veterinary Health, to form a group focused on the application of blockchain for learning credentials in the veterinary industry. The goal is to create a framework for competency-based medical education using digital badges to support credentialing.

Woburn, Mass. — November 1, 2019: Ethos Discovery is excited to announce a $5,000 grant received by Citizens Bank in support of the Ethos Discovery Research program. This contribution will help Ethos Discovery continue its work to improve health outcomes for humans and animals with complex medical problems.

Ethos Discovery recently announced its plan to deliver curative outcomes for dogs with splenic hemangiosarcoma. This will be achieved through a combination of genomic and precision medicine, and aligned prospective clinical trials collectively named ePUSH (Ethos Precision Medicine Umbrella Study for Hemangiosarcoma).

August 9, 2019, Woburn, MA and West Lafayette, IN: The Purdue University College of Veterinary Medicine has entered into a partnership with Ethos Veterinary Health and VetBloom, an innovative veterinary learning ecosystem, to create a pathway that allows members to earn an online veterinary nursing degree through Purdue University. The new partnership will allow VetBloom

Article originally published in NEWStat, an American Animal Hospital Association Publication  Written by Tony McReynolds Who measures the measurements? Who diagnoses the diagnostics? In short, who assays the assays? Veterinarians have been using polymerase chain reaction for antigen receptor rearrangement (PARR), a readily available molecular assay that helps diagnose some kinds of canine lymphoma, for years.

For the beta test trial, veterinarians at Mass Vet used LexaGene’s genetic analyzer to determine the cause of an infection and whether antibiotic resistance factors were present that could influence therapy decisions. They focused on processing canine and feline urine samples, but were given the opportunity to load other sample types onto the instrument such as swabs from surgical incisions, cervical swellings, and neck and chest wounds.

Lincoln Memorial University-College of Veterinary Medicine recognized Ethos Veterinary Health and the Massachusetts Veterinary Referral Hospital (Mass Vet), with the Distinguished Clinical Affiliate Award in recognition of the vital role the clinical partner played in preparing LMU-CVM graduates. Dr. Beth Eisenberg, veterinary criticalist for Ethos Veterinary Health and a veterinarian for Mass Vet, accepted the award at the LMU-CVM Commencement Ceremony on May 18 in Harrogate, Tennessee.

Ethos Veterinary Health today announced the addition of two hospital groups: Wisconsin Veterinary Referral Center (WVRC), with three locations in Wisconsin, and Pet Emergency & Specialty Center of Marin (PESCM), located in San Rafael, Calif. The two entities substantially add to Ethos’ hospital network. WVRC extends Ethos’ Midwest footprint into Southern Wisconsin, and PESCM adds to Ethos’ existing presence in Northern California.